Novo Nordisk Introduces Oral Wegovy in the U.S., Reshaping the Competitive Landscape in Obesity Care
Novo Nordisk has entered a new phase of the obesity treatment market with the commercial launch of an oral version […]
Novo Nordisk has entered a new phase of the obesity treatment market with the commercial launch of an oral version […]
Beckman Coulter Life Sciences has strengthened its leadership team in India with the appointment of Atul Shah as General Manager […]
Senior Indian Administrative Service (IAS) officer, Manoj Joshi, has assumed charge as the Secretary of the Department of Pharmaceuticals (DoP) […]
Intas Pharmaceuticals has entered into an exclusive strategic partnership with IntegriMedical to introduce a needle-free injection system for use in […]
The Ministry of Health and Family Welfare of India has imposed a nationwide ban on the manufacture, sale, and distribution […]
Jubilant Pharmova Ltd. has announced a strategic overseas investment aimed at expanding its branded generics footprint in North America. Jubilant […]
Zydus Group has announced the elevation of Dr. Tushar Nahata to Vice President, marking a key leadership advancement as the […]
Hyderabad-based Aurobindo Pharma Ltd has announced plans to acquire up to a 26% equity stake in Swarnaakshu Solar Power Private […]
Akums Drugs & Pharmaceuticals Ltd, a leading contract development and manufacturing organisation (CDMO), has entered into a Memorandum of Understanding […]
The Subject Expert Committee (SEC) under India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has accepted the Phase […]
Amneal Pharmaceuticals and mAbxience, a majority-owned subsidiary of Fresenius Kabi with partial ownership from Insud Pharma, have received U.S. Food […]
CuraTeQ Biologics Private Limited, the biologics-focused subsidiary of Aurobindo Pharma Limited, has decided to mutually terminate its licensing agreement with […]
Bengaluru-headquartered Biocon Limited has entered into an out-licensing agreement with Ajanta Pharma Ltd to commercialise its GLP-1–based anti-diabetes therapy Semaglutide […]